Public limited company · Bruxelles · incorporated on 09/04/1982 · 39,9 ETP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015 | 2014 | 2013 | 2009 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 71,3 M € | +2.6% | 69,5 M € | +5.0% | 66,2 M € | +13.6% | 58,2 M € | +19.4% | 48,8 M € | +16.4% | 41,9 M € | +9.9% | 38,1 M € | +42.6% | 26,7 M € | -0.8% | 26,9 M € | +1.2% | 26,6 M € | +3.7% | 25,7 M € | +7.0% | 24,0 M € | +11.8% | 21,5 M € | |
| EBITDA | 3,5 M € | +22.5% | 2,8 M € | +31.5% | 2,1 M € | +17.8% | 1,8 M € | +4.2% | 1,7 M € | +26.3% | 1,4 M € | -23.4% | 1,8 M € | +138.5% | 756,2 k € | -54.9% | 1,7 M € | +49.5% | 1,1 M € | -11.9% | 1,3 M € | -13.3% | 1,5 M € | -14.2% | 1,7 M € | |
| Operating profit | 3,4 M € | +23.8% | 2,8 M € | +27.7% | 2,2 M € | +24.5% | 1,7 M € | -0.0% | 1,7 M € | +25.9% | 1,4 M € | -25.0% | 1,8 M € | +199.6% | 612,6 k € | -61.4% | 1,6 M € | +57.8% | 1,0 M € | -13.5% | 1,2 M € | -14.0% | 1,3 M € | -17.8% | 1,6 M € | |
| Profit/loss | 4,2 M € | -17.7% | 5,1 M € | +34.3% | 3,8 M € | +172.1% | 1,4 M € | +19.9% | 1,2 M € | +1.8% | 1,1 M € | -31.5% | 1,7 M € | +84.4% | 898,8 k € | -51.7% | 1,9 M € | +12.7% | 1,7 M € | -32.6% | 2,4 M € | -4.8% | 2,6 M € | -44.1% | 4,6 M € | |
| Equity | 119,9 M € | +3.6% | 115,7 M € | +4.6% | 110,6 M € | +3.5% | 106,9 M € | +1.3% | 105,5 M € | +1.1% | 104,3 M € | +1.1% | 103,2 M € | +3.1% | 100,1 M € | +0.9% | 99,2 M € | +1.9% | 97,3 M € | +1.7% | 95,7 M € | -2.4% | 98,0 M € | +7.0% | 91,5 M € | |
| Total assets | 134,4 M € | +7.1% | 125,5 M € | -0.8% | 126,5 M € | +1.6% | 124,5 M € | +10.5% | 112,7 M € | -1.4% | 114,2 M € | +4.3% | 109,6 M € | +2.8% | 106,6 M € | +1.8% | 104,6 M € | +1.5% | 103,1 M € | -2.4% | 105,6 M € | +4.0% | 101,6 M € | +6.3% | 95,6 M € | |
| Cash | 252,0 € | -28.0% | 350,0 € | — | — | — | — | — | — | 63,1 € | -100.0% | 1,1 M € | +291.7% | 277,7 k € | -70.7% | 947,1 k € | +63.9% | 578,0 k € | ||||||||
| Debts | 14,4 M € | +47.4% | 9,8 M € | -38.3% | 15,9 M € | -9.7% | 17,6 M € | +144.9% | 7,2 M € | -27.6% | 9,9 M € | +55.5% | 6,4 M € | -1.7% | 6,5 M € | +21.0% | 5,4 M € | -5.1% | 5,6 M € | -43.0% | 9,9 M € | +175.2% | 3,6 M € | -7.3% | 3,9 M € | |
| Staff | 39,9 | 42,9 | 42,1 | 39,7 | 41,4 | 33,3 | 30,8 | 23,7 | 24,7 | 26,4 | 29,1 | 30,3 | 35,9 | |||||||||||||
Public limited company profitable and well capitalised. Cash position declining (-28.0%).
Solid counterparty for a standard engagement.
Ipsen is a Public limited company incorporated in 1982. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Bruxelles. It employs on average 39,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette